Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RGIN Stock Summary
In the News
RGIN Financial details
Company Rating
Buy
Market Cap
15.35K
Income
-596.34K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
0.66
Current Ratio
0.66
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-23.73%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.01%
Inst Trans
1%
ROA
-7%
ROE
13%
ROC
0.13%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
153.48M
Shs Float
153.46M
-
-
-
-
Target Price
-
52W Range
1.0E-4-0.0054
52W High
-
52W Low
-
RSI
26.91
Rel Volume
-
Avg Volume
-
Volume
2.46K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
-80%
-
-
-
-
Beta
-2.433
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0001
Change
0%
RGIN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-09-30
Metric | History | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | -0.01 | 0 | -0.01 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 | |
Tangible book value per share | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 | |
Share holders equity per share | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 5.34M | 2.92M | 1.84M | 3.07M | 491.15K | |
Enterprise value | 5.7M | 3.37M | 2.42M | 3.67M | 1.12M | |
P/E ratio | -9.55 | -3.76 | -3.04 | -3.37 | -0.71 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -39.94 | -22.99 | -14.95 | -127.33 | -18 | |
PFCF ratio | -39.94 | -22.99 | -14.95 | -127.33 | -18 | |
P/B Ratio | -1.78 | -0.78 | -0.43 | -0.59 | -0.09 | |
PTB ratio | -1.78 | -0.78 | -0.43 | -0.59 | -0.09 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -10.55 | -4.58 | -4.74 | -4.36 | -1.86 | |
EV to operating cash flow | -42.62 | -26.56 | -19.63 | -152.27 | -41.02 | |
EV to free cash flow | -42.62 | -26.56 | -19.63 | -152.27 | -41.02 | |
Earnings yield | -0.1 | -0.27 | -0.33 | -0.3 | -1.41 | |
Free cash flow yield | -0.03 | -0.04 | -0.07 | -0.01 | -0.06 | |
Debt to equity | -0.12 | -0.12 | -0.13 | -0.12 | -0.11 | |
Debt to assets | 6.38 | 85.53 | 139.66 | 130.81 | 41.49 | |
Net debt to EBITDA | -0.66 | -0.62 | -1.13 | -0.71 | -1.05 | |
Current ratio | 0.02 | 0 | 0 | 0 | 0 | |
Interest coverage | -28.77 | -41.03 | -10.86 | -24.27 | -16.58 | |
Income quality | 0.24 | 0.17 | 0.22 | 0.03 | 0.04 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.04 | 0.05 | 0.05 | 0.07 | 0.06 | |
ROIC | 0.2 | 0.23 | 0.15 | 0.19 | 0.13 | |
Return on tangible assets | -9.91 | -146.08 | -146.5 | -197.83 | -44.79 | |
Graham Net | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 | |
Working capital | -3M | -3.73M | -4.29M | -5.16M | -5.6M | |
Tangible asset value | -3M | -3.73M | -4.29M | -5.16M | -5.6M | |
Net current asset value | -3M | -3.73M | -4.29M | -5.16M | -5.6M | |
Invested capital | -0.12 | -0.12 | -0.13 | -0.12 | -0.11 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 174.25K | 102.92K | 113.48K | 91.17K | 98.4K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 62.61 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 5.83 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.19 | 0.21 | 0.14 | 0.18 | 0.12 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0.08 | 0.08 | 0 | 0 | |
Book value per share | -0.04 | -0.04 | -0.04 | 0 | 0 | |
Tangible book value per share | -0.04 | -0.04 | -0.04 | 0 | 0 | |
Share holders equity per share | -0.04 | -0.04 | -0.04 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 491.15K | 76.74K | 214.88K | 0 | 0 | |
Enterprise value | 1.12M | -11.07M | -10.02M | 0 | 0 | |
P/E ratio | -0.65 | -0.06 | -0.18 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -6.55K | -0.21 | -0.65 | 0 | 0 | |
PFCF ratio | -6.55K | -0.21 | -0.65 | 0 | 0 | |
P/B Ratio | -0.09 | -0.01 | -0.03 | 0 | 0 | |
PTB ratio | -0.09 | -0.01 | -0.03 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -7.65 | 41.38 | 30.65 | 0 | 0 | |
EV to operating cash flow | -14.93K | 30.61 | 30.53 | 0 | 0 | |
EV to free cash flow | -14.93K | 30.61 | 30.53 | 0 | 0 | |
Earnings yield | -0.39 | -3.86 | -1.4 | 0 | 0 | |
Free cash flow yield | 0 | -4.71 | -1.53 | 0 | 0 | |
Debt to equity | -0.11 | -0.11 | -0.1 | 0 | 0 | |
Debt to assets | 41.49 | 0.05 | 0.05 | 0 | 0 | |
Net debt to EBITDA | -4.29 | 41.67 | 31.31 | 0 | 0 | |
Current ratio | 0 | 0.67 | 0.66 | 0 | 0 | |
Interest coverage | -15.73 | -28.49 | -39.26 | 0 | 0 | |
Income quality | 0 | 1.3 | 0.98 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.03 | 0.04 | 0.04 | 0 | 0 | |
ROIC | 0.04 | 0.05 | 0.06 | 0 | 0 | |
Return on tangible assets | -12.27 | -0.03 | -0.03 | 0 | 0 | |
Graham Net | -0.04 | -0.04 | -0.04 | 0 | 0 | |
Working capital | -5.6M | -5.87M | -6.21M | 0 | 0 | |
Tangible asset value | -5.6M | -5.87M | -6.21M | 0 | 0 | |
Net current asset value | -5.6M | -5.87M | -6.21M | 0 | 0 | |
Invested capital | -0.11 | -0.11 | -0.1 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 94.06K | 54.2K | 2.64K | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.03 | 0.05 | 0.05 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
RGIN Frequently Asked Questions
What is Regenicin, Inc. stock symbol ?
Regenicin, Inc. is a US stock , located in Little falls of Nj and trading under the symbol RGIN
What is Regenicin, Inc. stock quote today ?
Regenicin, Inc. stock price is $0.0001 today.
Is Regenicin, Inc. stock public?
Yes, Regenicin, Inc. is a publicly traded company.